SMHBETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN
Provides 2x leveraged monthly-compounded exposure to the Solactive US Small Cap High Dividend Index, less Accrued Fees.
By UBS · Launched 2018
0.85%
#4,514 of 5,861 · expensive
$21M
#4,418 of 5,861 · small
+11.3%
7 years
#1,810 of 5,861 · established
Performance
Total-return NAV · USDTotal-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityRegion
North americaStrategy
Leveraged
Index tracked
Solactive US Small Cap High Dividend Index
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsYear-on-year price swings
Worst peak-to-trough loss
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Provides 2x leveraged monthly-compounded exposure to the Solactive US Small Cap High Dividend Index, less Accrued Fees.
- Strategy
- Provides 2x leveraged long exposure to the compounded monthly performance of the Solactive US Small Cap High Dividend Index — U.S.-listed small-cap high-dividend equities. Resets on a Monthly Reset Date (not daily-reset) and pays a variable monthly coupon linked to leveraged cash distributions from index constituents, less an Accrued Tracking Fee and Financing Charges.
- Inception date
- November 8, 2018
- Fund family
- UBS
Similar funds
Same asset class, closest by strategy & exposureOur take
Structural notes on how this fund behaves. Read our guide on the 6 warning signs.
Your return drifts the longer you hold
Leverage amplifies the index's daily move, by 2x or 3x. The fund resets every day, so over weeks and months your real return drifts from that multiple. It can run ahead in a smooth climb and bleed in a choppy one. Hold one for months and you own a different bet than the label suggests.
Sources: Cheng & Madhavan, 'The Dynamics of Leveraged and Inverse ETFs' (2009)
Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More
What's next?
You've looked at SMHB. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-04